Pulmonary hypertension and valvular heart disease

Area of Science:

• Cardiology
• Pulmonology
• Cardiovascular Surgery

Background:

• Pulmonary hypertension (PH) significantly impacts morbidity and mortality in patients with left-sided heart disease, particularly valvular heart disease.
• Elevated left atrial pressure is a primary driver of post-capillary PH in this population.
• While valve repair improves PH, pre- and post-interventional PH remains a critical predictor of long-term outcomes.

Purpose of the Study:

• To review current knowledge on PH in valvular heart disease, incorporating new hemodynamic definitions.
• To focus on characterizing hemodynamics, cardiopulmonary interaction, and managing residual PH post-valve intervention.
• To highlight the role of tricuspid regurgitation and patient selection for interventions.

Main Methods:

• Review of current literature on pulmonary hypertension in valvular heart disease.
• Analysis of new hemodynamic PH definitions and pre- vs. post-capillary components.
• Discussion of cardiopulmonary interactions and management strategies for residual PH and tricuspid regurgitation.

Main Results:

• Pulmonary hypertension, even after intervention, is a significant predictor of long-term outcomes in valvular heart disease.
• Precise hemodynamic characterization and understanding cardiopulmonary interactions are crucial.
• Tricuspid regurgitation, primary or functional, requires careful patient selection for intervention.

Conclusions:

• Pulmonary hypertension in valvular heart disease necessitates a comprehensive approach, considering hemodynamic nuances and residual disease.
• Management strategies for residual PH and tricuspid regurgitation are critical for improving patient outcomes.
• Further research is needed to address evidence gaps and refine future therapeutic perspectives.